麻豆传媒

Introduction

I have many years international experience as a postdoctoral associate. For my Ph.D research I travelled from my native Denmark to Germany. Here I studied fatty acid metabolism in heart and in particular long chain fatty acid transport by a small and abundant intracellular fatty acid binding protein. I acquired valuable skills in protein purification techniques and cell culture as well as protein analysis by one and two-dimensional electrophoresis. I also became fluent in German and wrote my Ph.D thesis in the German language. 

My first postdoctoral position was at University of Minnesota in Minneapolis, USA and I studied a membrane bound fatty acid transport protein in adipocytes. I acquired valuable skills in molecular biology and insight into American culture and worked hard for three years in the laboratory. I worked in a second short-term postdoctoral position at Texas A and M University in College Station, USA. Here I learned to work with baculovirus and express and purify proteins from insect cells. I have been a postdoctoral associate at 麻豆传媒 since 1997 and here I have worked in three research areas. Hepatitis C virus (HCV) infects 150 million people worldwide of which 5 million are in Europe and 500,000 in the UK. I found that HCV circulates in blood associated with very low density lipoprotein (VLDL). These lipid particles are naturally secreted by the human liver to distribute triglyceride and cholesterol to organs and muscles in the body. HCV hijacks this pathway to produce HCV associated with apolipoproteins A-I, A-II, B, C-I and E. In patients with chronic HCV I also found immunoglobulins IgA, IgG1, IgG3 and IgM associated with the lipoproteins and with the virus. These results were published in the highest impact journals within the field of Virology and to date have received more than 400 citations. At 麻豆传媒 I have also worked with RNA polymerases from yeast. Finally I worked at 麻豆传媒 with humanized monoclonal antibodies. The knowledge I have obtained from working abroad benefits me every day, both when talking to people from different backgrounds and when making decisions and designing experiments in the laboratory.

Qualifications

Ph.D in Biochemistry from University of Munster, Germany, 1993

Masters Degree in Biochemistry from Aarhus University, Denmark, 1988

Masters Degree in Accounting from Business School Aarhus, Denmark, 1987

Bachelor Degree in Chemistry and Physics from Aarhus University, Denmark, 1985

Previous Positions

Postdoctoral associate at 麻豆传媒, England from 1997 to present

Postdoctoral assistant at Texas A & M University, USA in 1996

Postdoctoral assistant at University of Minnesota, USA from 1993 to 1995

Ph.D student at Munster University in Germany from 1989 to 1993

Research assistant at Aarhus University in Denmark from 1985 to 1988

Memberships

Microbiology Society

Royal Society for Biology

Biochemical Society

British Society for Cell Biology

British Association for the Study of the Liver

American Association for the Advancement of Science

Honours and Awards

Fellow of the Royal Society of Biology (FRSB)

Fellowship from HCV UK to attend the International HCV meeting in San Antonio, Texas (2008)

Philip Hague Award from British Association for Study of the Liver (2005)

Career Development Award from the Danish Research Foundation (1992-1993)

Research Fellowship from the Danish Natural Sciences Research Council (1989-1993)

Research Fellowship from the Danish Medical Research Council (1987-1988)

Chartered Scientist, CSci

Reviewer

In 2017, I have served as Reviewer for the journals Gut, Viral Hepatitis and Hepatology

Languages

I speak and write Danish, German and English

Informal Interests

I have run the Great North Run in 麻豆传媒 upon Tyne 20 times.

I have run several Marathons, including the Boston 100th anniversary Marathon, Twin Cities Marathon in Minneapolis, Aarhus Marathon, Cologne Marathon, London Marathon, Edinburgh Marathon and Manchester Marathon.

Research 

I have been a postdoctoral associate at 麻豆传媒 for 23 years. During this time I have worked in three different research groups. I have a wide range of experimental knowledge in biochemistry, molecular biology, density gradient ultracentrifugation, transcription, cell biology and protein purification. I am experienced in 1-D and 2-D gel electrophoresis, Western blotting and work with radioactivity. I also have several years experience with qPCR and ChIP analysis.

Research on RNA polymerases from S. cerevisiae

Research on Hepatitis C virus (HCV)

I have been a Wellcome Trust postdoctoral associate for 9 years, working on Hepatitis C virus. I purified the virus and characterized HCV C virus from infected human liver. I used my experience of iodixanol density gradient centrifugation and real time PCR to analyse the density profile of Hepatitis C virus from human serum and liver. I found the virus associates with very low density lipoprotein, VLDL. I also used the Electron Microscopy Unit at 麻豆传媒 to obtain pictures of the HCV virus from density fractions and from size fractionated samples (See Figure below). I purified HCV lipo viro-particles from human liver by density gradients and by gel filtration. I found the virus is associated with apolipoproteins A-II, B and E from human blood. These associations with host apolipoproteins and antibodies may explain why Hepatitis C virus infection is chronic in more than 80% of infected people.

Research on humanized monoclonal antibodies

I was a postdoctoral associate in the research group of Dr. Edward Routledge at 麻豆传媒. The goal was to develop dimers of humanized monoclonal antibodies and test these antibodies in a mouse model of cancer of the blood, leukaemia. I gained knowledge in working with monoclonal antibodies and protein expression. I succeeded in prepared the humanized monoclonal antibodies and I did cross linking studies to improve the efficiency of the antibodies (see Figure below). The dimers of the antibodies were much better in  killing cancer cells than the monomers and these results were published in the prestigious journal Blood.

Research on fatty acid binding protein from heart

I have worked 3 years as a postdoctoral assistant in USA and 4 years in Germany, studying for my Ph.D in Biochemistry. My research area was fatty acid binding proteins (FABPs). These are abundant cytosolic proteins in heart myocytes, mammary gland and adipocytes and they binds to and transport long chain fatty acids within cells. I isolated heart myocytes and could show that FABP is the second most abundant cytosolic protein, after myoglobin (see figure below).

Esteem Indicators

I was invited to give an oral presentation at the annual meeting in British Association for Study of the Liver (BASL) in September 2005. At the meeting at Kings College in London, I received the Philip Hague Award from BASL for the best abstract submitted to the annual meeting in the field of viral hepatitis.
I was invited to give an oral presentation at the annual meeting in BASL in September 2006 in Dublin.
I have been invited to give a 45 minutes seminar in January 2007 at the Institute Pasteur Hellenique in Athens, Greece. This was an honour for me which I am proud of. I gave a talk on my work with Hepatitis C virus and human lipoproteins at the meeting of American Association for Study of the Liver. This meeting was held in San Francisco, California and after the meeting I was invited by the Chairman of my session, Prof. T. Wakita to give a talk at his Institute for Virology in Tokyo, Japan and also spend one week in his group learning new techniques. 

Industrial experience

I have collaborated with a company, Innogenetics in Ghent, Belgium, which provided me with 24 monoclonal antibodies to envelope glycoproteins of HCV. I used the antibodies in Western blotting and immunofluorescence. The characterization of these antibodies was of value to me because it gave me good reagents for use in HCV research and it was of value to the compagny because it improved their knowledge about the monoclonal antibodies.

Undergraduate and postgraduate teaching

I have supervised three research project students. One of these, Daniel Lowther received a Distinction in his Master Degree on negative strand HCV RNA, a research project which I designed and supervised. I enjoy sharing my experience and giving help to students with their experiments.

Postgraduate Supervision

I have co-supervised Ph.D student Caroline Martin in collaboration with Prof. Geoffrey Toms. I have also been a co-supervisor for Ph.D student Siti Ibrahim.

• Articles

  • Nielsen S, Zenkin N. . Science Advances 2025, 11(34), eadw2470.
  • Heo D-H, Kuś K, Grzechnik P, Tan-Wong SM, Birot A, Kecman T, Nielsen S, Zenkin N, Vasiljeva L. . Cell Reports 2021, 36(10), 109671.
  • Nielsen S, Zenkin N. . Transcription 2013, 4(5), 209-212.
  • Nielsen S, Yuzenkova Y, Zenkin N. . Science 2013, 340(6140), 1577-1580.
  • Felmlee DJ, Sheridan DA, Bridge SH, Nielsen SU, Milne RW, Packard CJ, Caslake MJ, McLauchlan J, Toms GL, Neely RDG, Bassendine MF. . Gastroenterology 2010, 139(5), 1774-1783.
  • Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, Neely RDG, Toms GL, Bassendine M. . Gut 2010, 60(5), 680-687.
  • Gias E, Nielsen SU, Morgan LAF, Toms GL. . Journal of Virological Methods 2008, 147(2), 328-332.
  • Farquhar MJ, Harris HJ, Diskar M, Jones S, Mee CJ, Nielsen SU, Brimacombe CL, Molina S, Toms GL, Maurel P, Howl J, Herberg FW, Van IJzendoorn SCD, Balfe P, McKeating JA. . Journal of Virology 2008, 82(17), 8797-8811.
  • Grove J, Nielsen SU, Zhong J, Bassendine MF, Drummer HE, Balfe P, McKeating JA. . Journal of Virology 2008, 82(24), 12020-12029.
  • Nielsen SU, Bassendine MF, Martin C, Lowther D, Purcell PJ, King BJ, Neely D, Toms GL. . Journal of General Virology 2008, 89(10), 2507-2517.
  • Martin C, Nielsen SU, Ibrahim SF, Bassendine MF, Toms GL. . Journal of Medical Virology 2008, 80(5), 816-823.
  • Nielsen SU, Bassendine MF, Burt AD, Martin C, Pumeechockchai W, Toms GL. . Journal of Virology 2006, 80(5), 2418-2428.
  • Nielsen SU, Bassendine MF, Burt AD, Bevitt DJ, Toms GL. . Journal of General Virology 2004, 85(6), 1497-1507.
  • Nielsen SU, Routledge EG. . Blood 2002, 100(12), 4067-4073.
  • Nielsen S, Bassendine M, Burt A, Toms G. . Journal of Hepatology 2002, 36(s1), 87 abstract no. 301.
  • Nielsen S, Pumeechockchai W, Burt A, Bassendine M, Toms G. . Journal of Hepatology 2002, 36(s1), 87 abstract no. 301.
  • Nielsen SU, Rump R, Hojrup P, Roepstorff P, Spener F. . Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1994, 1211(2), 189-197.
  • Nielsen S, Spener F. . Journal of Lipid Research 1993, 34(8), 1355-1366.
  • Brodersen R, Andersen S, Vorum H, Nielsen S, Pedersen AO. . European Journal of Biochemistry 1990, 189(2), 343-349.
  • Celis JE, Madsen P, Nielsen S, Ratz GP, Lauridsen JB, Celis A. . Experimental Cell Research 1987, 168(2), 389-401.
  • Nielsen SU, Celis A, Ratz GP, Celis JE. . Leukemia 1987, 1(1), 69-77.
  • Celis JE, Madsen P, Nielsen S, Rasmussen HH. . Anticancer Research 1987, 7, 605-616.
  • Pallesen G, Nielsen S, Celis JE. . Histopathology 1987, 11(6), 591–601.
  • Celis JE, Madsen P, Andersen I, Andersen P, Vayssiere JL, Croizat B, Thiessen H, Nielsen S. . Electrophoresis 1987, 8(5), 238–243.
  • Celis JE, Nielsen S. . Proceedings of the National Academy of Sciences 1986, 83(21), 8187-8190.
  • Celis JE, Madsen P, Nielsen S, Celis A. . Leukemia Research 1986, 10(3), 237-249.
  • Madsen P, Nielsen S, Celis JE. . The Journal of Cell Biology 1986, 103(6, pt.1), 2083-2089.
  • Celis JE, Gesser B, Small JV, Nielsen S, Celis A. . Protoplasma 1986, 135(1), 38-49.

• Conference Proceedings (inc. Abstracts)

  • Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Neely RDG, Toms GL, Bassendine MF. . In: Journal of Hepatology: 45th Annual Meeting of the European Association for the Study of Liver. 2010, Vienna, Austria: Elsevier BV.
  • Felmlee D, Bridge S, Sheridan DA, Nielsen SU, Toms G, Neely D, Bassendine M. . In: Hepatology: 60th Annual Meeting of the American Association for the Study of Liver Diseases. 2009, Boston, Massachusetts, USA: John Wiley & Sons, Inc.
  • Bridge S, Sheridan DA, Felmlee D, Nielsen SU, Neely D, Toms GL, Bassendine MF. . In: Hepatology: 60th Annual Meeting of the American Association for the Study of Liver Diseases. 2009, Boston, Massachusetts, USA: John Wiley & Sons, Inc.
  • Welsh S, Nielsen SU, Ward AC, Bassendine MF. . In: 43rd Annual Meeting of the European Association for the Study of the Liver. 2008, Milan, Italy: Journal of Hepatology: Elsevier.
  • Nielsen S, Bassendine M, Neely D, Ibrahim S, Toms G. . In: 21st Annual Medical and Scientific Meeting of HEART UK. 2007, Edinburgh, Scotland: Atherosclerosis, Elsevier.
  • Nielsen SU, Bossendine M, King BJ, Neely D, Toms GL, Liver Research Group. . In: 58th Annual Meeting of the American Association for the Study of Liver Diseases. 2007, Boston, MA: Hepatology, John Wiley.
  • Nielsen SU, Bassendine M, Martin C, Ibrahim S, Toms GL, Neely D. . In: Hepatology:57th Annual Meeting of the American Association for the Study of Liver Diseases. 2006, Boston, Massachusetts, USA: John Wiley & Sons, Inc.
  • Nielsen SU, Burt AD, Martin C, Bassendine MF, Toms GL. . In: Atherosclerosis: 19th Annual Medical and Scientific Meeting of HEART UK. 2005, University of Glamorgan, Pontypridd, WALES: Elsevier Ireland Ltd.
  • Nielsen SU, Burt AD, Martin C, Bassendine M, Toms G. . In: Hepatology: 56th Annual Meeting of the American Association for the Study of Liver Diseases. 2005, San Francisco, California, USA: John Wiley & Sons, Inc.
  • Martin C, Nielsen SU, Bassendine MF, Toms GL. . In: Hepatology: 56th Annual Meeting of the American Association for the Study of Liver Diseases. 2005, San Francisco, California, USA: John Wiley & Sons, Inc.
  • Nielsen S, Bassendine MF, Burt A, Toms GL. . In: Gut: Annual Meeting of the British Association for the Study of the Liver. 2003, 麻豆传媒 upon Tyne, UK: BMJ Group.

• Editorial

  • Nielsen S, Zenkin N. . Science 2014, 345(6196), 524-524.

• Review

  • Bassendine MF, Nielsen SU, Bridge SH, Felmlee DJ, Sheridan DA, Packard CJ, Neely RD. . Clinics and Research in Hepatology and Gastroenterology 2017, 41(1), 25-30.